News

Our latest press releases, media appearances and topical commentary.





News
03 November 2022
Medicines Discovery Catapult and Xerion Healthcare Secure Funding for Innovative Brain Tumour Treatment

Innovate UK SMART Grant awarded to accelerate progress to clinical trials





News
26 October 2022
Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise

New appointment reflects ambition for growth to drive drug discovery innovation


News
21 October 2022
Medicines Discovery Catapult Inspires Cheshire’s Future Scientists

School engagement programme reaches hundreds of local school children


News
25 August 2022
Global Expansion: Psychiatry Consortium Welcomes New International Partner

Medicines Discovery Catapult Welcome Shionogi to the Psychiatry Consortium


News
25 August 2022
Medicines Discovery Catapult and ZEISS Set Sights on Advancing Microscopy

Medicines Discovery Catapult Welcome Shionogi to the Psychiatry Consortium


News
27 July 2022
Genomics Nation 2022: Genomics Drives UK Life Science Success, New Report Finds

New report from UK BioIndustry Association, the Wellcome Sanger Institute and Medicines Discovery Catapult


News
13 June 2022
CF AMR Syndicate: Lifting the Limits of Cystic Fibrosis Antimicrobial Development

Medicines Discovery Catapult Supports Cystic Fibrosis Week 2022


News
27 May 2022
Getting Better With Age – Conference Set to Tackle UK’s “Ticking Time Bomb” of Age-Related Illnesses

Alderley Park conference aims to improve therapeutics for the UK’s ageing population






Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us



We are ISO 45001 certified 

The world’s first international standard for occupational health and safety. The accreditation has been certified by Interface NRM, a UKAS and ASI–accredited certification body.











Medicines Discovery Catapult